当前位置: 首页 > 期刊 > 《医学信息》 > 201423
编号:13677179
5种血清肿瘤标志物联合检测对肺癌诊断价值(2)
http://www.100md.com 2014年6月11日 陈祥娜
    参见附件。

     [3]Robert AH,Olivera IF.Human tumor antigens are ready to fly[J].Advance Immunology,1996,62:217.

    [4]Ando s,Kimura H,Lwai N,e tal.Optimal combination of seven tumormarkers in prediction of advanced stage at fist examination of patients with non-small cell lung cancer[J].Anticancer Ros,2001,21(4B):3085-3092.

    [5]郭忠燕,方曉慧,申咏梅,等.血清多种肿瘤标志物联合检测对肺癌的诊断价值[J]苏州大学学报(医学版),2011,31(5):789-792,808

    [6]Huang WW,Tsao SM,Lai CL,etal.Diagnostic value of Her-2/neu,Cyfra21-1,and carcinoembryonic antigeu levels in malignant pleural effusions of lung adenocarcinoma[J].Pathology,2010,42(3):224-228.

    [7]凌存保,田亚平,郭广宏,等援三种血清标志物在肺癌中的应用价值[J]援标记免疫分析与临床,2010,17(4):209-221

    [8]韩放,曲静,纪春艳.联合检测五种肿瘤标志物对肺癌的诊断价值[J]中国实用医药,2014,8(2):134-135

    [9] LEE G,GE B,HUANG T K,et al.Positive identification of CA125 pan cancer biomarker from serum specimens of cancer patients[J].Cancer Biomark,2010,6(2):111-117.

    [10]Ni XG,Bai XF,Mao YL,et a1.The clinical value of serum CEA,CA19-9 and CA242 in the diagnosis and prognosis of panerestic cancer[J].Eur J Surg Oncol,2005,31(2).

    编辑/王海静

    

您现在查看是摘要介绍页,详见PDF附件